No matter what the disease, an early diagnosis always gives medical personnel more opportunities for treatment and prevention. Nanoparticle Biomarker Tagging (NBT) technology offers powerful capabilities to screen for a wide range of diseases with unprecedented sensitivity that makes detection possible at some of the earliest instances of exposure or infection.
The ANCON Medical NBT device detects biomarkers, which act as chemical signatures for diseases, through the exhaled breath of an individual.
Already, biomarkers for 400 diseases have been discovered. With more funding, researchers can discover even more biomarkers. The ANCON Medical NBT device has potential to be a powerful tool in stopping the spread of diseases in poor and developing countries, making the company a compelling candidate for medical and research grant funding.